BCL2 and urinary bladder cancer: can induce apoptosis in cancer cells via the activation of pro-caspases and pro-apoptotic Bax and the inactivation of the anti-apoptotic Bcl-2 proteins [21,22], which may reduce chemotherapy toxicity and thereby might inhibit the progression of bladder cancer.